Grow your company.

How to become an Ohio State Early Investor Network Portfolio Company

Infographic on the process to pitch. Share: Click the button above. Connect: speak to our team. Profile: Invited companies build a profile. Meet: Invited companies are reviewed by our Investment Committee. Pitch: If selected pitch to the network.

Applying to pitch, sharing company information and/or meeting the minimum requirements does not guarantee access to the network or that you will receive a certain amount of investment. Investment decisions are made by the individual investors. OSEIN cannot guarantee any outcomes. Companies will be invited to create a profile based on initial information provided; contacting the network and providing information does not guarantee a company will be invited to create a profile. Companies are selected to pitch by a committee of network investors. Staff and committee members reserve the right to limit access to the network as needed.

Ohio State Early Investor Network Portfolio Companies

DASI Simulations delivers AI-driven digital twin software for structural heart procedures—enabling personalized, optimized treatment planning. Based in Dublin, Ohio, the company recently added three eminent cardiologists to its Medical Advisory Board and is now pre-planning complex TAVR cases in real-world clinical settings . With FDA clearance for its Dasi Dimensions product and new Medicare reimbursement for PrecisionTAVI, DASI continues to shape the future of structural heart care .

An OSU spinout founded in 2021 under Prof. Carlos Castro, DNA Nanobots engineers DNA origami–based nanoparticles for precision delivery of therapeutics. Recently closed its pre‑seed round, licensed UC Berkeley tech for non-viral CRISPR-Cas gene delivery, and welcomed Dr. John C. Byrd to its Scientific Advisory Board. Their BioPharma Partner Program supports in vivo development of targeted payloads, with strategic partnerships in oncology and rare disease therapeutics.

Led by OSU College of Medicine alum Dr. Kimberly Langdon ’91, Coologics is advancing Vlisse—a patented, drug-free intravaginal cooling device targeting yeast infections, BV, and preterm birth prevention. Fueling its progress, the company recently closed an oversubscribed $3M+ seed round and launched multi-center clinical trials this spring .

Five Star Fans is transforming NIL fundraising with its platform that allows fans to reward student-athletes directly during live plays. Co‑founded by former Buckeye cheerleaders, the startup has seen explosive growth—tens of thousands of dollars in rewards paid and a major NIL campaign featuring Ohio State athletes during the Spring Game . Tailored for the energetic college sports community, their PlayCast feature puts fans at the heart of recruitment and support.